{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T01:34:37Z","timestamp":1776994477633,"version":"3.51.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Econ Rev"],"DOI":"10.1186\/s13561-026-00755-7","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:07:15Z","timestamp":1773767235000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Economic burden and cost of non-adherence in type 2 diabetes: a systematic review of middle- and high-income countries"],"prefix":"10.1186","volume":"16","author":[{"given":"Piedad","family":"G\u00f3mez-Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel Rosario","family":"Bl\u00e1zquez-Ornat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luisa Lozano","family":"Del Hoyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma. Esther Samaniego-D\u00edaz","family":"de Corcuera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Ferrer-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Ram\u00f3n-Arbu\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sof\u00eda Pilar","family":"P\u00e9rez-Calahorra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"G\u00f3mez-Barrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Fern\u00e1ndez-Rodrigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"755_CR1","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 2024 Jan 1;47(Suppl 1): S20-S42. https:\/\/doi.org\/10.2337\/dc24-S002. PMID: 38078589; PMCID: PMC10725812.","DOI":"10.2337\/dc24-S002"},{"issue":"1","key":"755_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-018-3772-8","volume":"18","author":"A Afroz","year":"2018","unstructured":"Afroz A, Alramadan MJ, Hossain MN, Romero L, Alam K, Magliano DJ, et al. Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review. BMC Health Serv Res. 2018;18(1):1\u201310. https:\/\/doi.org\/10.1186\/s12913-018-3772-8.","journal-title":"BMC Health Serv Res"},{"key":"755_CR3","doi-asserted-by":"publisher","unstructured":"Aguirre Rodr\u00edguez JC, S\u00e1nchez Cambronero M, Guisasola C\u00e1rdenas M, Generoso Torres MN, Hidalgo Rodr\u00edguez A, Mart\u00edn Enguix D, et al. Diabetes tipo 2 en Andaluc\u00eda: uso de recursos y coste econ\u00f3mico [Type 2 diabetes in Andalusia: Resources use and economic cost]. Semergen.\u00a02023;49(8). https:\/\/doi.org\/10.1016\/j.semerg.2023.102066.","DOI":"10.1016\/j.semerg.2023.102066"},{"issue":"1","key":"755_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/pharmacy9010016","volume":"9","author":"G Alodhaib","year":"2021","unstructured":"Alodhaib G, Alhusaynan I, Mirza A, Almogbel Y. Qualitative exploration of barriers to medication adherence among patients with uncontrolled diabetes in Saudi Arabia. Pharmacy. 2021;9(1):16. https:\/\/doi.org\/10.3390\/pharmacy9010016.","journal-title":"Pharmacy"},{"issue":"8","key":"755_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.4239\/WJD.V10.I8.463","volume":"10","author":"MJ Alomar","year":"2019","unstructured":"Alomar MJ, Al-Ansari KR, Hassan NA. Comparison of awareness of diabetes mellitus type II with treatment\u2019s outcome in term of direct cost in a hospital in Saudi Arabia. World J Diabetes. 2019;10(8):463\u201372. https:\/\/doi.org\/10.4239\/WJD.V10.I8.463.","journal-title":"World J Diabetes"},{"issue":"6","key":"755_CR6","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/tbm\/ibz098","volume":"10","author":"AH Ariel-Donges","year":"2020","unstructured":"Ariel-Donges AH, Gordon EL, Dixon BN, Eastman AJ, Bauman V, Ross KM, et al. Rural\/urban disparities in access to the National Diabetes Prevention Program. Transl Behav Med. 2020;10(6):1554\u20138. https:\/\/doi.org\/10.1093\/tbm\/ibz098.","journal-title":"Transl Behav Med"},{"key":"755_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.vhri.2021.11.001","volume":"27","author":"F Augustovski","year":"2022","unstructured":"Augustovski F, Garc\u00eda Mart\u00ed S, Espinoza MA, Palacios A, Husereau D, Pichon-Riviere A. Est\u00e1ndares Consolidados de Reporte de Evaluaciones Econ\u00f3micas Sanitarias: adaptaci\u00f3n al espa\u00f1ol de la lista de comprobaci\u00f3n CHEERS 2022. Value in Health Regional Issues. 2022;27:110\u20134. https:\/\/doi.org\/10.1016\/j.vhri.2021.11.001.","journal-title":"Value in Health Regional Issues"},{"key":"755_CR8","doi-asserted-by":"publisher","unstructured":"Azeem S, Khan U, Liaquat A. The increasing rate of diabetes in Pakistan: a silent killer. Annals Med Surg. 2022;79. https:\/\/doi.org\/10.1016\/j.amsu.2022.103901.","DOI":"10.1016\/j.amsu.2022.103901"},{"issue":"5","key":"755_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41573-023-00670-0","volume":"22","author":"TH Baryakova","year":"2023","unstructured":"Baryakova TH, Pogostin BH, Langer R, McHugh KJ. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nat Rev Drug Discov 2023 22:5. 2023;22(5):387\u2013409. https:\/\/doi.org\/10.1038\/s41573-023-00670-0.","journal-title":"Nat Rev Drug Discov 2023 22:5"},{"issue":"2","key":"755_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21801\/ppcrj.2022.82.1","volume":"8","author":"A Bhandari","year":"2022","unstructured":"Bhandari A, Concha-Mejia A, Vasquez A, Peralta A, Rivera A, Vallejos G, et al. The impact of positive social reinforcement on time-to-attrition from the Diabetes Prevention Program in college students at high risk for Type II Diabetes: a study protocol for a phase 3, multicenter, cluster randomized trial. Principles Pract Clin Res J. 2022;8(2):1\u20138. https:\/\/doi.org\/10.21801\/ppcrj.2022.82.1.","journal-title":"Principles Pract Clin Res J"},{"issue":"4","key":"755_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1590\/s1135-57272010000400002","volume":"84","author":"F Catal\u00e1-L\u00f3pez","year":"2010","unstructured":"Catal\u00e1-L\u00f3pez F, Garc\u00eda-Alt\u00e9s A. Evaluaci\u00f3n econ\u00f3mica de intervenciones sanitarias en Espa\u00f1a durante el per\u00edodo 1983\u20132008. Rev Esp Salud Publica. 2010;84(4):353\u201369. https:\/\/doi.org\/10.1590\/s1135-57272010000400002.","journal-title":"Rev Esp Salud Publica"},{"issue":"1","key":"755_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.18553\/jmcp.2021.27.1.064","volume":"27","author":"C Chinthammit","year":"2021","unstructured":"Chinthammit C, Axon DR, Mollon L, Taylor AM, Pickering M, Black H, et al. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study. J Manag Care Spec Pharm. 2021;27(1):64\u201372. https:\/\/doi.org\/10.18553\/jmcp.2021.27.1.064.","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"755_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.18359\/rmed.6408","volume":"31","author":"AL Cubillos Osorio","year":"2023","unstructured":"Cubillos Osorio AL, Palencia S\u00e1nchez F, Ria\u00f1o Casallas M. Tendencias de la evidencia cient\u00edfica de las evaluaciones econ\u00f3micas y las enfermedades no transmisibles: un an\u00e1lisis bibliom\u00e9trico. Rev Med. 2023;31(1):59\u201374. https:\/\/doi.org\/10.18359\/rmed.6408.","journal-title":"Rev Med"},{"issue":"1","key":"755_CR14","doi-asserted-by":"publisher","first-page":"e016982","DOI":"10.1136\/bmjopen-2017-016982","volume":"8","author":"RL Cutler","year":"2018","unstructured":"Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982. https:\/\/doi.org\/10.1136\/bmjopen-2017-016982.","journal-title":"BMJ Open"},{"issue":"9","key":"755_CR15","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.18553\/jmcp.2020.26.9.1081","volume":"26","author":"EL Eby","year":"2020","unstructured":"Eby EL, Bajpai S, Faries DE, Haynes VS, Lage MJ. The association between adherence to insulin therapy and health care costs for adults with type 2 diabetes: evidence from a U.S. retrospective claims database. J Manag Care Spec Pharm. 2020;26(9):1081\u20139. https:\/\/doi.org\/10.18553\/jmcp.2020.26.9.1081.","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"755_CR16","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.2337\/dc23-S005","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 5. Facilitating positive health behaviors and well-being to improve health outcomes: standards of care in diabetes-2023. Diabetes Care. 2023;46(1):S68\u201396. https:\/\/doi.org\/10.2337\/dc23-S005.","journal-title":"Diabetes Care"},{"key":"755_CR17","doi-asserted-by":"publisher","first-page":"108734","DOI":"10.1016\/j.diabres.2021.108734","volume":"174","author":"M Gabler","year":"2021","unstructured":"Gabler M, Picker N, Geier S, Foersch J, Aberle J, Martin S, et al. Real-world clinical outcomes and costs in type 2 diabetes mellitus patients after initiation of insulin therapy: a German claims data analysis. Diabetes Res Clin Pract. 2021;174:108734. https:\/\/doi.org\/10.1016\/j.diabres.2021.108734.","journal-title":"Diabetes Res Clin Pract"},{"key":"755_CR18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s10198-021-01414-w","volume":"23","author":"L Garc\u00eda-Moch\u00f3n","year":"2022","unstructured":"Garc\u00eda-Moch\u00f3n L, \u0160pac\u00edrov\u00e1 Z, Esp\u00edn J. Costing methodologies in European economic evaluation guidelines: commonalities and divergences. Eur J Health Econ. 2022;23:979\u201391. https:\/\/doi.org\/10.1007\/s10198-021-01414-w.","journal-title":"Eur J Health Econ"},{"issue":"12","key":"755_CR19","doi-asserted-by":"publisher","first-page":"e049487","DOI":"10.1136\/bmjopen-2021-049487","volume":"11","author":"RJ Geurten","year":"2021","unstructured":"Geurten RJ, Elissen AMJ, Bilo HJG, Struijs JN, van Tilburg C, Ruwaard D. Identifying and delineating the type 2 diabetes population in the Netherlands using an all-payer claims database: characteristics, healthcare utilisation and expenditures. BMJ Open. 2021;11(12):e049487. https:\/\/doi.org\/10.1136\/bmjopen-2021-049487.","journal-title":"BMJ Open"},{"issue":"6","key":"755_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/14737167.2018.1503953","volume":"18","author":"AH Gillani","year":"2018","unstructured":"Gillani AH, Aziz MM, Masood I, Saqib A, Yang C, Chang J, et al. Direct and indirect cost of diabetes care among patients with type 2 diabetes in private clinics: a multicenter study in Punjab, Pakistan. Expert Rev Pharmacoecon Outcomes Res. 2018;18(6):647\u201353. https:\/\/doi.org\/10.1080\/14737167.2018.1503953.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"755_CR21","unstructured":"G\u00f3mez-Torres P, Bl\u00e1zquez-Ornat I, Lozano Del Hoyo ML, Samaniego-D\u00edaz de Corcuera ME, Ferrer-L\u00f3pez E, Ram\u00f3n-Arbu\u00e9s E, et al. Economic impact of diabetes and costs of non-adherence in middle and high-income countries: a systematic review. PROSPERO. 2024. https:\/\/www.crd.york.ac.uk\/prospero\/view\/crd42024519296."},{"key":"755_CR22","doi-asserted-by":"publisher","unstructured":"Guo K, Qiu J, Xue S, Pi L, Li X, Huang G, et al. Epidemiological status, development trends, and risk factors of disability-adjusted life years due to diabetic kidney disease: a systematic analysis of Global Burden of Disease Study 2021. Chin Med J. 2025;138(5). https:\/\/doi.org\/10.1097\/CM9.0000000000003428.","DOI":"10.1097\/CM9.0000000000003428"},{"key":"755_CR23","doi-asserted-by":"publisher","unstructured":"Hoyo MLLD, Rodrigo MTF, Urcola-Pardo F, Monreal-Bartolom\u00e9 A, Ruiz DCG, Borao MG, et al. The TELE-DD randomised controlled trial on treatment adherence in patients with type 2 diabetes and comorbid depression: clinical outcomes after 18-month follow-up. Int J Environ Res Public Health. 2022;20(1):328. https:\/\/doi.org\/10.3390\/ijerph20010328.","DOI":"10.3390\/ijerph20010328"},{"issue":"January","key":"755_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpubh.2025.1515797","volume":"13","author":"X Huang","year":"2025","unstructured":"Huang X, Wu Y, Ni Y, Xu H, He Y. Global, regional, and national burden of type 2 diabetes mellitus caused by high BMI from 1990 to 2021, and forecasts to 2045: analysis from the global burden of disease study 2021. Front Public Health. 2025;13(January):1\u201312. https:\/\/doi.org\/10.3389\/fpubh.2025.1515797.","journal-title":"Front Public Health"},{"issue":"5","key":"755_CR25","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1016\/j.dsx.2019.07.049","volume":"13","author":"SS Ibrahim Abougalambou","year":"2019","unstructured":"Ibrahim Abougalambou SS, AbaAlkhail H, Abougalambou AS. The knowledge, attitude and practice among diabetic patient in central region of Saudi Arabia. Diabetes Metab Syndr. 2019;13(5):2975\u201381. https:\/\/doi.org\/10.1016\/j.dsx.2019.07.049.","journal-title":"Diabetes Metab Syndr"},{"key":"755_CR26","unstructured":"International Diabetes Federation. Total diabetes-related health expenditure (USD million). In IDF Diabetes Atlas. 11th ed. 2024. Retrieved September 26, 2025, from https:\/\/diabetesatlas.org\/es\/data-by-indicator\/diabetes-related-health-expenditure\/total-diabetes-related-health-expenditure-usd-million\/."},{"key":"755_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2147\/PPA.S147233","volume":"12","author":"M Jaworski","year":"2018","unstructured":"Jaworski M, Panczyk M, Cedro M, Kucharska A. Adherence to dietary recommendations in diabetes mellitus: disease acceptance as a potential mediator. Patient Prefer Adherence. 2018;12:163\u201374. https:\/\/doi.org\/10.2147\/PPA.S147233.","journal-title":"Patient Prefer Adherence"},{"key":"755_CR28","doi-asserted-by":"publisher","unstructured":"Jim\u00e9nez-Gonz\u00e1lez Y, Rodr\u00edguez-Santamar\u00eda Y, Ju\u00e1rez-Medina LL, Mendoza-Catal\u00e1n G, Alarc\u00f3n-Luna NS, Ju\u00e1rez-De Llano AL. Relaci\u00f3n Entre Autocuidado Y Estigma Asociado a La Diabetes Tipo 2 En Adultos Mexicanos. Horizonte de Enfermeria, NE. 2023:128\u201341. https:\/\/doi.org\/10.7764\/horiz_enferm.num.esp.128-141.","DOI":"10.7764\/horiz_enferm.num.esp.128-141"},{"issue":"10","key":"755_CR29","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1111\/dme.14213","volume":"37","author":"K K\u00e4hm","year":"2020","unstructured":"K\u00e4hm K, Stark R, Laxy M, Schneider U, Leidl R. Assessment of excess medical costs for persons with type 2 diabetes according to age groups: an analysis of German health insurance claims data. Diabet Med. 2020;37(10):1752\u20138. https:\/\/doi.org\/10.1111\/dme.14213.","journal-title":"Diabet Med"},{"issue":"2","key":"755_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.5507\/bp.2024.009","volume":"168","author":"B Kolars","year":"2024","unstructured":"Kolars B, Minakovic I, Grabovac B, Zivanovic D, Jovin VM. Treatment adherence and the contemporary approach to treating type 2 diabetes mellitus. Biomed Pap. 2024;168(2):97\u2013104. https:\/\/doi.org\/10.5507\/bp.2024.009.","journal-title":"Biomed Pap"},{"key":"755_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-62122-y","author":"N Kov\u00e1cs","year":"2024","unstructured":"Kov\u00e1cs N, Shahin B, Andrade CAS, Mahrouseh N, Varga O. Lifestyle and metabolic risk factors, and diabetes mellitus prevalence in European countries from three waves of the European Health Interview Survey. Sci Rep. 2024. https:\/\/doi.org\/10.1038\/s41598-024-62122-y.","journal-title":"Sci Rep"},{"key":"755_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9626413","volume":"2019","author":"H-F Li","year":"2019","unstructured":"Li H-F, Cai L, Golden AR. Short-term trends in economic burden and catastrophic costs of type 2 diabetes mellitus in rural Southwest China. J Diabetes Res. 2019;2019:1\u20136. https:\/\/doi.org\/10.1155\/2019\/9626413.","journal-title":"J Diabetes Res"},{"issue":"3","key":"755_CR33","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1097\/JS9.0000000000002260","volume":"111","author":"J Li","year":"2025","unstructured":"Li J, Pandian V, Davidson PM, Song Y, Chen N, Fong DYT. Burden and attributable risk factors of non-communicable diseases and subtypes in 204 countries and territories, 1990-2021: a systematic analysis for the global burden of disease study 2021. Intern J Surg (London, England). 2025;111(3):2385\u201397. https:\/\/doi.org\/10.1097\/JS9.0000000000002260.","journal-title":"Intern J Surg (London, England)"},{"issue":"2","key":"755_CR34","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/jdi.12905","volume":"10","author":"X Li","year":"2019","unstructured":"Li X, Xu Z, Ji L, Guo L, Liu J, Feng K, et al. Direct medical costs for patients with type 2 diabetes in 16 tertiary hospitals in urban China: a multicenter prospective cohort study. J Diabetes Investig. 2019;10(2):539\u201351. https:\/\/doi.org\/10.1111\/jdi.12905.","journal-title":"J Diabetes Investig"},{"issue":"10","key":"755_CR35","doi-asserted-by":"publisher","first-page":"731","DOI":"10.47102\/annals-acadmedsg.202032","volume":"49","author":"GJ Lim","year":"2020","unstructured":"Lim GJ, Liu YL, Low S, Ang K, Tavintharan S, Sum CF, et al. Medical costs associated with severity of chronic kidney disease in type 2 diabetes mellitus in Singapore. Ann Acad Med Singapore. 2020;49(10):731\u201341. https:\/\/doi.org\/10.47102\/annals-acadmedsg.202032.","journal-title":"Ann Acad Med Singapore"},{"issue":"1","key":"755_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/dme.13193","volume":"34","author":"Q Long","year":"2017","unstructured":"Long Q, He M, Tang X, Allotey P, Tang S. Treatment of type 2 diabetes mellitus in Chongqing of China: unaffordable care for the poor. Diabet Med. 2017;34(1):120\u20136. https:\/\/doi.org\/10.1111\/dme.13193.","journal-title":"Diabet Med"},{"issue":"6","key":"755_CR37","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/dme.13619","volume":"35","author":"ZK Lum","year":"2018","unstructured":"Lum ZK, Tsou KYK, Lee JY-C. Mediators of medication adherence and glycaemic control and their implications for direct outpatient medical costs: a cross-sectional study. Diabet Med. 2018;35(6):807\u201315. https:\/\/doi.org\/10.1111\/dme.13619.","journal-title":"Diabet Med"},{"issue":"6","key":"755_CR38","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jval.2016.09.2399","volume":"20","author":"C Lunghi","year":"2017","unstructured":"Lunghi C, Moisan J, Gr\u00e9goire JP, Gu\u00e9nette L. The association between depression and medication nonpersistence in new users of antidiabetic drugs. Value Health. 2017;20(6):728\u201335. https:\/\/doi.org\/10.1016\/j.jval.2016.09.2399.","journal-title":"Value Health"},{"issue":"11","key":"755_CR39","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/IJCP.12502","volume":"68","author":"C McAdam-Marx","year":"2014","unstructured":"McAdam-Marx C, Bellows BK, Unni S, Mukherjee J, Wygant G, Iloeje U, et al. Determinants of glycaemic control in a practice setting: the role of weight loss and treatment adherence (The DELTA Study). Int J Clin Pract. 2014;68(11):1309\u201317. https:\/\/doi.org\/10.1111\/IJCP.12502.","journal-title":"Int J Clin Pract"},{"issue":"11","key":"755_CR40","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1111\/dme.13023","volume":"33","author":"KA McBrien","year":"2016","unstructured":"McBrien KA, Manns BJ, Hemmelgarn BR, Weaver R, Edwards AL, Ivers N, et al. The association between sociodemographic and clinical characteristics and poor glycaemic control: a longitudinal cohort study. Diabet Med. 2016;33(11):1499\u2013507. https:\/\/doi.org\/10.1111\/dme.13023.","journal-title":"Diabet Med"},{"issue":"1","key":"755_CR41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s13300-017-0361-5","volume":"9","author":"A McGovern","year":"2018","unstructured":"McGovern A, Hinton W, Calderara S, Munro N, Whyte M, de Lusignan S. A class comparison of medication persistence in people with type 2 diabetes: a retrospective observational study. Diabetes Ther. 2018;9(1):229\u201342. https:\/\/doi.org\/10.1007\/s13300-017-0361-5.","journal-title":"Diabetes Ther"},{"key":"755_CR42","doi-asserted-by":"publisher","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Antes G, Atkins D, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6(7).\u00a0https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"755_CR43","unstructured":"National Institute for Health and Care Excellence.\u00a0Type 2 diabetes in adults: Management (NICE guideline NG28). NICE;\u00a02022. https:\/\/www.nice.org.uk\/guidance\/ng28."},{"issue":"10","key":"755_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.endonu.2016.08.003","volume":"63","author":"R Nu\u00f1o-Solin\u00eds","year":"2016","unstructured":"Nu\u00f1o-Solin\u00eds R, Alonso-Mor\u00e1n E, Arteagoitia Axpe JM, Ezkurra Loiola P, Orueta JF, Gaztambide S. Costes sanitarios de la poblaci\u00f3n con diabetes mellitus tipo 2 en el Pa\u00eds Vasco (Espa\u00f1a). Endocrinol Nutr. 2016;63(10):543\u201350. https:\/\/doi.org\/10.1016\/j.endonu.2016.08.003.","journal-title":"Endocrinol Nutr"},{"key":"755_CR45","unstructured":"OECD. Health at a Glance 2021. 2021.\u00a0https:\/\/www.oecd.org\/en\/publications\/health-at-a-glance-2021_ae3016b9-en.html."},{"issue":"1","key":"755_CR46","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12889-021-10450-3","volume":"21","author":"S-H Oh","year":"2021","unstructured":"Oh S-H, Ku H, Park KS. Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data. BMC Public Health. 2021;21(1):548. https:\/\/doi.org\/10.1186\/s12889-021-10450-3.","journal-title":"BMC Public Health"},{"issue":"7","key":"755_CR47","doi-asserted-by":"publisher","first-page":"635","DOI":"10.7196\/samj.2021.v111i7.15169","volume":"111","author":"AM Opperman","year":"2021","unstructured":"Opperman AM, de Klerk M. A total cost perspective of type 1 and 2 diabetes mellitus in two SouthAfrican medical schemes servicing the public healthcare sector. S Afr Med J. 2021;111(7):635\u201341. https:\/\/doi.org\/10.7196\/samj.2021.v111i7.15169.","journal-title":"S Afr Med J"},{"issue":"1","key":"755_CR48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2337\/dci23-0085","volume":"47","author":"ED Parker","year":"2024","unstructured":"Parker ED, Lin J, Mahoney T, Ume N, Yang G, Gabbay RA, et al. Economic costs of diabetes in the U.S. in 2022. Diabetes Care. 2024;47(1):26\u201343. https:\/\/doi.org\/10.2337\/dci23-0085.","journal-title":"Diabetes Care"},{"issue":"1","key":"755_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11892-024-01574-y","volume":"25","author":"S Plebon-Huff","year":"2025","unstructured":"Plebon-Huff S, Haji-Mohamed H, Gardiner H, Ghanem S, Koh J, LeBlanc AG. Contextualization of diabetes: a review of reviews from Organisation for Economic Co-operation and Development (OECD) countries. Curr Diabetes Rep. 2025;25(1):19. https:\/\/doi.org\/10.1007\/s11892-024-01574-y.","journal-title":"Curr Diabetes Rep"},{"issue":"10","key":"755_CR50","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1017\/S1368980014002444","volume":"18","author":"C Puett","year":"2015","unstructured":"Puett C, Guerrero S. Barriers to access for severe acute malnutrition treatment services in Pakistan and Ethiopia: a comparative qualitative analysis. Public Health Nutr. 2015;18(10):1873\u201382. https:\/\/doi.org\/10.1017\/S1368980014002444.","journal-title":"Public Health Nutr"},{"issue":"1","key":"755_CR51","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/medicina61010153","volume":"61","author":"U Religioni","year":"2025","unstructured":"Religioni U, Barrios-Rodr\u00edguez R, Requena P, Borowska M, Ostrowski J. Enhancing therapy adherence: impact on clinical outcomes, healthcare costs, and patient quality of life. Medicina. 2025;61(1):153. https:\/\/doi.org\/10.3390\/medicina61010153.","journal-title":"Medicina"},{"issue":"3","key":"755_CR52","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/0020731421996168","volume":"51","author":"MA Rodwin","year":"2021","unstructured":"Rodwin MA. Common pharmaceutical price and cost controls in the United Kingdom, France, and Germany: lessons for the United States. Int J Health Serv. 2021;51(3):379\u201391. https:\/\/doi.org\/10.1177\/0020731421996168.","journal-title":"Int J Health Serv"},{"issue":"2","key":"755_CR53","doi-asserted-by":"publisher","first-page":"8","DOI":"10.29166\/rfcmq.v45i2.2661","volume":"45","author":"G Rojas Velasco","year":"2020","unstructured":"Rojas Velasco G, Sol\u00eds P, Gaona R, Nunes A. Evaluaci\u00f3n de Sitagliptina para el tratamiento de pacientes adultos con diabetes mellitus tipo 2: revisi\u00f3n sistem\u00e1tica de costo-efectividad. Revista de La Facultad de Ciencias M\u00e9dicas (Quito). 2020;45(2):8\u201320. https:\/\/doi.org\/10.29166\/rfcmq.v45i2.2661.","journal-title":"Revista de La Facultad de Ciencias M\u00e9dicas (Quito)"},{"key":"755_CR54","unstructured":"SED, S. E. de D. Espa\u00f1a es el segundo pa\u00eds con mayor prevalencia de diabetes de Europa.\u00a02019.\u00a0https:\/\/www.sediabetes.org\/comunicacion\/sala-de-prensa\/espana-es-el-segundo-pais-con-mayor-prevalencia-de-diabetes-de-europa\/."},{"key":"755_CR55","unstructured":"SEMERGEN, S. E. de M. de A. P., Peral Mart\u00ednez, I., Miravet Jim\u00e9nez, S., Abril Rubio, A., Arjona Bravo, A., Arranz Mart\u00ednez, E., Burguillos Dur\u00e1n, M., L\u00f3pez Simarro, F., (SEMERGEN), S. E. de M. de A. P., Mediavilla Bravo, J., Novillo L\u00f3pez, C., Olivares Loro, A., P\u00e9rez Unanua, M. P., Ruiz Garc\u00eda, A., & Tur\u00e9gano Yedro, M. (2024). Gu\u00edas Cl\u00ednicas SEMERGEN: Manejo pr\u00e1ctico del paciente con DM2 en Atenci\u00f3n Primaria."},{"issue":"1\u20132","key":"755_CR56","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/10497323231206964","volume":"34","author":"N Shahabi","year":"2024","unstructured":"Shahabi N, Hosseini Z, Aghamolaei T, Behzad A, Ghanbarnejad A, Dadipoor S. Determinants of adherence to treatment in type 2 diabetic patients: a directed qualitative content analysis based on Pender\u2019s Health Promotion Model. Qual Health Res. 2024;34(1\u20132):114\u201325. https:\/\/doi.org\/10.1177\/10497323231206964.","journal-title":"Qual Health Res"},{"issue":"6","key":"755_CR57","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S2213-8587(15)00135-7","volume":"3","author":"FJ Snoek","year":"2015","unstructured":"Snoek FJ, Bremmer MA, Hermanns N. Constructs of depression and distress in diabetes: time for an appraisal. Lancet Diabetes Endocrinol. 2015;3(6):450\u201360. https:\/\/doi.org\/10.1016\/S2213-8587(15)00135-7.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"755_CR58","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. https:\/\/doi.org\/10.1016\/j.diabres.2021.109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"755_CR59","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s40615-018-0488-8","volume":"5","author":"X Sun","year":"2018","unstructured":"Sun X, Liabsuetrakul T, Xie X, Liu P, Zhang Y, Wang Z. Ethnic disparity in annual healthcare expenditures for type 2 diabetes mellitus in Ningxia, China. J Racial Ethn Health Disparities. 2018;5(6):1381\u20138. https:\/\/doi.org\/10.1007\/s40615-018-0488-8.","journal-title":"J Racial Ethn Health Disparities"},{"key":"755_CR60","doi-asserted-by":"publisher","unstructured":"Suri Ari K, Dwi E, Tri Murti A, Anna Wahyuni W. Direct and indirect cost of diabetes mellitus in Indonesia: a prevalence based study with human capital approach. Intern J Pharma Res. 2020;13(01). https:\/\/doi.org\/10.31838\/ijpr\/2021.13.01.331.","DOI":"10.31838\/ijpr\/2021.13.01.331"},{"issue":"2","key":"755_CR61","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1185\/03007995.2015.1119677","volume":"32","author":"M Tiktin","year":"2016","unstructured":"Tiktin M, Celik S, Berard L. Understanding adherence to medications in type 2 diabetes care and clinical trials to overcome barriers: a narrative review. Curr Med Res Opin. 2016;32(2):277\u201387. https:\/\/doi.org\/10.1185\/03007995.2015.1119677.","journal-title":"Curr Med Res Opin"},{"key":"755_CR62","doi-asserted-by":"publisher","unstructured":"Venditti V, Bleve E, Morano S, Filardi T. Gender-related factors in medication adherence for metabolic and cardiovascular health. Metabolites. 2023;13(10).\u00a0https:\/\/doi.org\/10.3390\/metabo13101087.","DOI":"10.3390\/metabo13101087"},{"key":"755_CR63","unstructured":"WHO. Indonesia\u2019s success in achieving 90 percent coverage and minimizing out-of-pocket expenses through national health insurance expansion.\u00a02023.\u00a0https:\/\/www.who.int\/about\/accountability\/results\/who-results-report-2020-mtr\/country-story\/2023\/indonesia-s-success-in-achieving-90-percent-coverage-and-minimizing-out-of-pocket-expenses-through-national-health-insurance-expansion."},{"key":"755_CR64","unstructured":"WHO. Diabetes. 2024.\u00a0https:\/\/www.who.int\/es\/news-room\/fact-sheets\/detail\/diabetes."},{"key":"755_CR65","unstructured":"World Bank. Clasificaci\u00f3n de los pa\u00edses elaborada por el Grupo Banco Mundial seg\u00fan los niveles de ingreso para el a\u00f1o fiscal 24 (1 de julio de 2023\u201330 de junio de 2024) [Blog post]. World Bank Data Blog. 2023.\u00a0https:\/\/blogs.worldbank.org\/es\/opendata\/clasificacion-de-los-paises-elaborada-por-el-grupo-banco-mundial-segun-los-niveles-de-ingreso."},{"key":"755_CR66","unstructured":"World Bank. GDP (current US$). In World Development Indicators. 2024. Retrieved September 26, 2025, from https:\/\/databank.worldbank.org\/reports.aspx?series=NY.GDP.MKTP.CD&source=2."},{"issue":"2","key":"755_CR67","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/jdi.12897","volume":"10","author":"H Wu","year":"2019","unstructured":"Wu H, Eggleston KN, Zhong J, Hu R, Wang C, Xie K, et al. Direct medical cost of diabetes in rural China using electronic insurance claims data and diabetes management data. J Diabetes Investig. 2019;10(2):531\u20138. https:\/\/doi.org\/10.1111\/jdi.12897.","journal-title":"J Diabetes Investig"},{"issue":"6","key":"755_CR68","doi-asserted-by":"publisher","first-page":"E176","DOI":"10.37765\/ajmc.2023.89376","volume":"29","author":"M Zakeri","year":"2023","unstructured":"Zakeri M, Lewing BD, Contreras J, Sansgiry SS. Economic burden of nonadherence to standards of diabetes care. Am J Manag Care. 2023;29(6):E176\u201383. https:\/\/doi.org\/10.37765\/ajmc.2023.89376.","journal-title":"Am J Manag Care"},{"issue":"10027","key":"755_CR69","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/s0140-6736(16)00618-8","volume":"387","author":"B Zhou","year":"2016","unstructured":"Zhou B, Lu Y, Hajifathalian K, Bentham J, Di Cesare M, Danaei G, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513\u201330. https:\/\/doi.org\/10.1016\/s0140-6736(16)00618-8.","journal-title":"Lancet"}],"container-title":["Health Economics Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13561-026-00755-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13561-026-00755-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13561-026-00755-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:42:45Z","timestamp":1776991365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13561-026-00755-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["755"],"URL":"https:\/\/doi.org\/10.1186\/s13561-026-00755-7","relation":{},"ISSN":["2191-1991"],"issn-type":[{"value":"2191-1991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a systematic review and did not involve the collection of original human data. Therefore, ethical approval was not required. The methodology followed PRISMA guidelines, and all data included were extracted from previously published, peer-reviewed sources.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}